Akebia Ther Stock Analysis

Akebia Stock Analysis Notes

About 27.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.22. Akebia Ther had not issued any dividends in recent years. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Akebia Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 426 people. For more info on Akebia Ther please contact John MBA at 617 871 2098 or go to https://www.akebia.com.

Akebia Ther Investment Alerts

Akebia Ther Upcoming and Recent Events

Akebia Largest EPS Surprises

View All Earnings Estimates

Akebia Stock Institutional Investors

Note, although Akebia Ther's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Akebia Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 410.18 M.

Akebia Profitablity

The company has Profit Margin (PM) of (0.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.33.

Management Efficiency

Akebia Ther has return on total asset (ROA) of (0.0937) % which means that it has lost $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5345) %, meaning that it created substantial loss on money invested by shareholders. Akebia Ther's management efficiency ratios could be used to measure how well Akebia Ther manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.78, whereas Return On Tangible Assets are forecasted to decline to (0.37). At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 182 M, whereas Other Current Assets are forecasted to decline to about 12.6 M.

Technical Drivers

As of the 26th of November, Akebia Ther shows the risk adjusted performance of 0.096, and Mean Deviation of 2.54. Akebia Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Akebia Ther Price Movement Analysis

Akebia Ther Insider Trading Activities

Akebia Ther Outstanding Bonds

Akebia Ther Predictive Daily Indicators

Akebia Ther Forecast Models

Akebia Ther's time-series forecasting models are one of many Akebia Ther's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Akebia Ther's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Akebia Ther prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Akebia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Akebia Ther. By using and applying Akebia Stock analysis, traders can create a robust methodology for identifying Akebia entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Akebia analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Akebia analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Akebia Ther stock analysis indicators help investors evaluate how Akebia Ther stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Akebia Ther shares will generate the highest return on investment. By understating and applying Akebia Ther stock analysis, traders can identify Akebia Ther position entry and exit signals to maximize returns.

When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.